Moderna appoints Tal Zaks CMO
This article was originally published in Scrip
Cambridge, Massachusetts-based Moderna Therapeutics, a company developing messenger RNA (mRNA) Therapeutics across a range of therapeutic applications, has named Dr Tal Zaks chief medical officer. Prior to joining Moderna, Dr Zaks was senior vice-president and head of global oncology at Sanofi, where he was responsible for all aspects of oncology drug discovery, development and commercialization.
You may also be interested in...
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the novel coronavirus pandemic. While Biopharma companies secured more than $7.5bn in private financings between January and June.
Experts discuss the future of brain health, changing the stereotypical view of an Alzheimer’s patient and how technology and science have evolved the treatment possibilities for dementia patients in 2020 – even if ‘clinical practice is taking a long time to catch up.’
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.